Abstract
COVID-19, with its complications and co-infections is the most important pandemic, which has placed great strain on even the most developed health care systems, especially on the kidney transplant patients. We present a case of cytomegalovirus (CMV) reactivation after remission of COVID-19 in a kidney transplant patient, admitted to the emergency department. Fever, dyspnea, weakness and tachypnea are the most common symptoms of COVID-19, which can mislead physicians to make inappropriate decisions. We concluded that CMV can potentially increase the mortality risk of kidney transplant recipients (KTRs).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
